Status: current, Defined. Date: 31-Dec 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3161591000168115 | bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3161601000168110 | bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | bictegravir + emtricitabine + tenofovir alafenamide | true | Inferred relationship | Some | ||
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | true | Inferred relationship | Some | ||
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1977403175 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has Australian BoSS | bictegravir | true | Inferred relationship | Some | 1810099460 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has intended active ingredient | bictegravir | true | Inferred relationship | Some | 1810099460 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has intended active ingredient | tenofovir alafenamide | true | Inferred relationship | Some | 1977403174 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has Australian BoSS | tenofovir alafenamide | true | Inferred relationship | Some | 1977403174 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 505213230 | |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 505213230 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet, 30 | has MPUU | True | bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some | 1 |
| Biktarvy tablet | Is a | True | bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR